Condensed Consolidated Statements Of Changes in Stockholders' Equity (Deficit) - USD ($) $ in Thousands	Total	Common Stock [Member]	Additional Paid-in Capital	Accumulated Deficit
Balance at beginning of period (in shares) at Dec. 31, 2024		30,663,000
Balance at beginning of period at Dec. 31, 2024	$ 93,989	$ 3	$ 750,174	$ (656,188)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon vesting of restricted stock awards (in shares)	3,054		3,054
Issuance of common stock upon exercise of stock options and ESPP shares purchased (in shares)		3,000
Issuance of common stock upon vesting of restricted stock units (in shares)		156,000
Issuance of common stock (in shares)		592,000
Issuance of common stock	5,111		5,111
Withholding of restricted stock to satisfy tax withholding obligations upon the vesting of the related restricted stock		(58,000)
Withholding of restricted stock to satisfy tax withholding obligations upon the vesting of the related restricted stock	(492)		(492)
Net loss	(12,813)			(12,813)
Balance at end of period (in shares) at Mar. 31, 2025		31,356,000
Balance at end of period at Mar. 31, 2025	$ 88,849	$ 3	757,847	(669,001)
Balance at beginning of period (in shares) at Dec. 31, 2025	35,930,000	35,930,000
Balance at beginning of period at Dec. 31, 2025	$ 94,875	$ 4	821,319	(726,448)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon vesting of restricted stock awards (in shares)	4,421		4,421
Issuance of common stock upon exercise of stock options and ESPP shares purchased (in shares)		9,000
Issuance of common stock upon exercise of stock options	7		7
Issuance of common stock upon vesting of restricted stock units (in shares)		324,000
Issuance of common stock (in shares)		631,000
Issuance of common stock	14,204		14,204
Withholding of restricted stock to satisfy tax withholding obligations upon the vesting of the related restricted stock		(127,000)
Withholding of restricted stock to satisfy tax withholding obligations upon the vesting of the related restricted stock	(3,039)		(3,039)
Net loss	$ (29,663)			(29,663)
Balance at end of period (in shares) at Mar. 31, 2026	36,767,000	36,767,000
Balance at end of period at Mar. 31, 2026	$ 80,805	$ 4	$ 836,912	$ (756,111)